Skip to main content
Clinical Trials/NCT03291236
NCT03291236UnknownNot Applicable

Survival Outcomes of Uterine Cervical Malignancies in Chinese Population

Lei Li1 site in 1 country5,000 target enrollmentStarted: January 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
5,000
Locations
1
Primary Endpoint
Overall survival

Study Overview

Brief Summary

This study aims to determine survival outcomes (overall survival and progression-free survival) of primary malignancies of uterine cervix in China and relevant risk factors in a prospective cohort study.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Primary malignancies of uterine cervix.

Exclusion Criteria

  • Secondary malignancies of uternie cervix.

Outcomes

Primary Outcomes

Overall survival

Time Frame: 5 years

Duration from diagnosis to recurrence

Progression-free survival

Time Frame: 5 years

Duration from last treatment after remission to recurrence

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Lei Li
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Lei Li

Professor

Peking Union Medical College Hospital

Study Sites (1)

Loading locations...

Similar Trials